{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:00:31Z","timestamp":1792479631891,"version":"4.5.0"},"reference-count":47,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T00:00:00Z","timestamp":1273190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Helicobacter"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Background:\u2002<\/jats:bold>\n                    The success rate of currently recommended 7\u2010day triple therapy with a PPI plus amoxicillin and clarithromycin has fallen into the unacceptable range. It is urgent to look for a new strategy to treat the infection of\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    .\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Aims:\u2002<\/jats:bold>\n                    To observe the efficacy of triple therapy\u2010based, bismuth\u2010containing quadruple therapy for\n                    <jats:italic>H. pylori<\/jats:italic>\n                    treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:\u2002<\/jats:bold>\n                    A total of 160 patients with functional dyspepsia who were\n                    <jats:italic>Hp<\/jats:italic>\n                    + were randomly assigned into two groups. Regimen: Omeprazole 20\u2003mg, Amoxicillin 1.0\u2003g, Clarithromycin 500\u2003mg and Bismuth Potassium Citrate 220\u2003mg, twice a day. Eighty patients received 7\u2010day quadruple therapy and 80 patients received the same therapy for 14\u2003days. Six weeks after treatment,\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication was assessed by\n                    <jats:sup>13<\/jats:sup>\n                    C\u2010urea breath test. Minimal inhibitory concentrations of metronidazole, clarithromycin and amoxicillin of clinical isolates were determined by the twofold agar dilution method.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:\u2002<\/jats:bold>\n                    Fourteen\u2010day therapy led to a significant increase of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication success when compared to 7\u2010day therapy in the intention\u2010to\u2010treat analysis (93.7 vs 80.0%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2003=\u2003.01), and the per\u2010protocol analysis (97.4 vs 82.0%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2003=\u2003.0016). The\n                    <jats:italic>H. pylori<\/jats:italic>\n                    resistance rates to metronidazole, clarithromycin and amoxicillin were 42.1, 18.0 and 0%. Fourteen\u2010day therapy was significantly more effective in patients with clarithromycin\u2010resistant strains. Incidences of adverse events were comparable.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:\u2002<\/jats:bold>\n                    Addition bismuth and prolonging treatment duration can overcome\n                    <jats:italic>H. pylori<\/jats:italic>\n                    resistance to clarithromycin and decrease the bacterial load. Fourteen\u2010day triple therapy\u2010based, bismuth\u2010containing quadruple therapy achieved ITT success rate 93% and could be recommended as the first line eradication regimen.\n                  <\/jats:p>","DOI":"10.1111\/j.1523-5378.2010.00758.x","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T17:05:09Z","timestamp":1273251909000},"page":"233-238","source":"Crossref","is-referenced-by-count":97,"title":["High Efficacy of 14\u2010Day Triple Therapy\u2010Based, Bismuth\u2010Containing Quadruple Therapy for Initial\n                    <i>Helicobacter pylori<\/i>\n                    Eradication"],"prefix":"10.1111","volume":"15","author":[{"given":"Qinjuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shudong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,5,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00518.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02029.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1155\/2006\/258768"},{"key":"e_1_2_6_5_2","first-page":"531","article-title":"A clinical study of proton pump inhibitor\u2010containing quadruple regimen as first\u2010line therapy for Helicobacter pylori eradication","volume":"12","author":"Mu F","year":"2007","journal-title":"Chin J Gastroenterol"},{"key":"e_1_2_6_6_2","first-page":"645","article-title":"Comparison of efficacy of 7\u2010day rabeprazole\u2010based triple therapy versus quadruple therapy for treatment of Helicobacter pylori infection","volume":"11","author":"Zheng Q","year":"2006","journal-title":"Chin J Gastroenterol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200868060-00001"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.7361"},{"issue":"1","key":"e_1_2_6_10_2","first-page":"42","article-title":"The third national consensus report on several issues of Helicobacter pylori infection","volume":"13","author":"H. pylori Study Group, Chinese Society of Gastroenterology","year":"2008","journal-title":"Chin J Gastroenterol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-3-20"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80044-X"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1155\/2006\/258768"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.563"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181c8a1a3"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.05982.x"},{"issue":"1","key":"e_1_2_6_17_2","first-page":"M1053","article-title":"The 10\u2010day sequential therapy for Helicobacter pylori eradication in Korea: Less effective than expected","volume":"136","author":"Park S","year":"2009","journal-title":"Gastroenterology"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.125658"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00671.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.09.030"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"issue":"1","key":"e_1_2_6_22_2","first-page":"19","article-title":"Eradication of Helicobacter pylori: A clinical update","volume":"6","author":"Romano M","year":"2004","journal-title":"MedGenMed"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093298"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00716.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03384.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199001001-00023"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpgasthep1138"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/419784"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90606-3"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.22163000.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198836020-00002"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70145-X"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.6.1983-1988.2004"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2005.00288.x"},{"issue":"12","key":"e_1_2_6_35_2","first-page":"1545","article-title":"Drug therapy for Helicobacter pylori infection. Problems and pitfalls","volume":"85","author":"Glupczynski Y","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/516084"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00344.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01592.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2006.00459.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00744.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1155\/2003\/714124"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2006.03.004"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00656.x"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.102269"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00468.x"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2007.02.018"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00008"},{"issue":"1","key":"e_1_2_6_48_2","first-page":"8","article-title":"Comparison of the efficacy of pantoprazole based triple therapy versus quadruple therapy in the treatment of Helicobacter pylori infection: A single\u2010center, randomized, open and parallel\u2010controlled study","volume":"14","author":"Zheng Q","year":"2009","journal-title":"Chin J Gastroenterol"}],"container-title":["Helicobacter"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1523-5378.2010.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1523-5378.2010.00758.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:18:55Z","timestamp":1698632335000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1523-5378.2010.00758.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,7]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1523-5378.2010.00758.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-5378.2010.00758.x","archive":["Portico"],"relation":{},"ISSN":["1083-4389","1523-5378"],"issn-type":[{"value":"1083-4389","type":"print"},{"value":"1523-5378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,7]]}}}